Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NETT Sends Mostly Positive Message for Controversial Lung Procedure

This article was originally published in Start Up

Executive Summary

The mystery is over; the results of the National Emphysema Treatment Trial Research Group (NETT) have been unveiled, and it's by and large good news for device companies in interventional pulmonology. Although the outcomes are mixed and underscore the need for proper patient selection, clinicians are now hoping that clinical benefits demonstrated by NETT, a 1218-patient, five-year randomized prospective clinical trial comparing lung volume reduction surgery to medical management, will support reimbursement for the surgery.
Advertisement

Related Content

VIDA Diagnostics
Aeris Therapeutics Inc.
Uptake Medical Corp.
Devices Fill The Lung Space
Devices Fill The Lung Space
Emphasys Medical Inc.
In Heart Valves, a Brave, New, Non-Surgical World
In Heart Valves, a Brave, New, Non-Surgical World
Pulmonology: The Next Interventional Cardiology
Pulmonology: The Next Interventional Cardiology

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT037266

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel